Skip to main content

Table 5 Immune related adverse effects

From: Peripheral blood biomarkers correlate with outcomes in advanced non-small cell lung Cancer patients treated with anti-PD-1 antibodies

  N = 157
Immune side effects
 No 98 (62.4%)
 Yes 59 (37.6%)
Pneumonitis
 Grade 1–2 13 (8.2%)
 Grade ≥ 3 2 (1.3%)
Colitis
 Grade 1–2 7 (4.4%)
 Grade ≥ 3 1 (0.6%)
Rash
 Grade 1–2 10 (6.3%)
 Grade ≥ 3 1 (0.6%)
Thyroiditis
 Grade 1–2 27 (17.2%)
 Grade ≥ 3 2 (1.3%)
Hepatitis
 Grade 1–2 7 (4.4%)
 Grade ≥ 3 1 (0.6%)
Nephritis
 Grade 1–2 7 (4.4%)
Steroid use due to side effects N = 59
 No 27 (45.8%)
 Yes 32 (54.2%)